Corporate Information

Key Members

Alexei Gladkov President

1989: Received a Master’s degree in Philosophy from Novosibirsk University
2002: Received a Master’s degree in Business Administration in Moscow With over 28 years of International Business experience, 22 years were based actively in Japan. These included the fields of International Medical Tourism, Internet and Software Development, Biotechnology related development work and more.
2010: Personally, underwent bone marrow derived mesenchymal stem cell therapy and recognized its positive potential
2014: Established Kintaro Cells Power Co. Ltd in Japan based on advanced cell cultivation technology.

Nina Gladkova Medical Director (Doctor of Medicine)

In 1997, Dr. Nina Gladkova was assigned as the Chief Executive Officer of Novosibirsk Medical Clinic. Then, in 2001, she studied cell culture at the Biotechnology Institute in Russia. By 2009, Dr. Gladkova become the research director of I.C.I.D, designing and organizing workshops about utilizing Russian biotechnology, and human resource education. In 2013, she was involved in the research on practical application of cell culture as a medical director (of Medical Grid). Dr. Gladkova become the Medical Director of Kintaro Cells Power in 2014, and engaged in comprehensive research and laboratory management in practical field of regenerative medicine.

Dr. Junko Oyashiki Medical Partner (Doctor of Medicine)

Graduated from Tokyo Medical University with a Doctor of Medicine in 1978. From 1984 to 1986, she was engaged in genetic research at the State Rose Park Cancer Institute in New York State, USA. From January 2009 to March 2018, Dr. Oyashiki was a professor at Tokyo Medical University Medical Research Institute and worked on cell therapy research using exosomes. Since April 2018, Dr. Junko Oyashiki has been working as a Professor for the Tokyo Medical University Cell therapy research and development course (industry-university cooperative course). Currently, Dr. Junko Oyashiki and Tokyo Medical University are conducting joint research with Kintaro Cells Power Corporation on bone marrow-derived mesenchymal stem cells.